Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationship between insulin-like growth factor I levels, early insulin treatment, and clinical outcomes of very low birth weight infants.
Beardsall K, Vanhaesebrouck S, Frystyk J, Ogilvy-Stuart AL, Vanhole C, van Weissenbruch M, Midgley P, Thio M, Cornette L, Gill B, Ossuetta I, Iglesias I, Theyskens C, de Jong M, Ahluwalia JS, de Zegher F, Dunger DB; NIRTURE Study Group. Beardsall K, et al. J Pediatr. 2014 May;164(5):1038-1044.e1. doi: 10.1016/j.jpeds.2013.12.046. Epub 2014 Feb 8. J Pediatr. 2014. PMID: 24518169 Clinical Trial.
Validation of the continuous glucose monitoring sensor in preterm infants.
Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, Vanhole C, VanWeissenbruch M, Midgley P, Thio M, Cornette L, Ossuetta I, Palmer CR, Iglesias I, de Jong M, Gill B, de Zegher F, Dunger DB. Beardsall K, et al. Arch Dis Child Fetal Neonatal Ed. 2013 Mar;98(2):F136-40. doi: 10.1136/archdischild-2012-301661. Epub 2012 Jul 12. Arch Dis Child Fetal Neonatal Ed. 2013. PMID: 22791467 Clinical Trial.
Prevalence and determinants of hyperglycemia in very low birth weight infants: cohort analyses of the NIRTURE study.
Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, Vanhole C, Palmer CR, Ong K, vanWeissenbruch M, Midgley P, Thompson M, Thio M, Cornette L, Ossuetta I, Iglesias I, Theyskens C, de Jong M, Gill B, Ahluwalia JS, de Zegher F, Dunger DB. Beardsall K, et al. J Pediatr. 2010 Nov;157(5):715-9.e1-3. doi: 10.1016/j.jpeds.2010.04.032. Epub 2010 Jun 8. J Pediatr. 2010. PMID: 20570286
A selective small-molecule agonist of G protein-gated inwardly-rectifying potassium channels reduces epileptiform activity in mouse models of tumor-associated and provoked seizures.
Rifkin RA, Wu X, Pereira B, Gill BJ, Merricks EM, Michalak AJ, Goldberg AR, Humala N, Dovas A, Rai G, McKhann GM, Slesinger PA, Canoll P, Schevon C. Rifkin RA, et al. Among authors: gill bj. Neuropharmacology. 2025 Mar 1;265:110259. doi: 10.1016/j.neuropharm.2024.110259. Epub 2024 Dec 9. Neuropharmacology. 2025. PMID: 39662702
Glioma-Induced Alterations in Excitatory Neurons are Reversed by mTOR Inhibition.
Goldberg AR, Dovas A, Torres D, Sharma SD, Mela A, Merricks EM, Olabarria M, Shokooh LA, Zhao HT, Kotidis C, Calvaresi P, Viswanathan A, Banu MA, Razavilar A, Sudhakar TD, Saxena A, Chokran C, Humala N, Mahajan A, Xu W, Metz JB, Chen C, Bushong EA, Boassa D, Ellisman MH, Hillman EMC, McKhann GM 2nd, Gill BJA, Rosenfeld SS, Schevon CA, Bruce JN, Sims PA, Peterka DS, Canoll P. Goldberg AR, et al. Among authors: gill bja. bioRxiv [Preprint]. 2024 Jan 21:2024.01.10.575092. doi: 10.1101/2024.01.10.575092. bioRxiv. 2024. PMID: 38293120 Free PMC article. Preprint.
Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients.
Lee IY, Hanft S, Schulder M, Judy KD, Wong ET, Elder JB, Evans LT, Zuccarello M, Wu J, Aulakh S, Agarwal V, Ramakrishna R, Gill BJ, Quiñones-Hinojosa A, Brennan C, Zacharia BE, Silva Correia CE, Diwanji M, Pennock GK, Scott C, Perez-Olle R, Andrews DW, Boockvar JA. Lee IY, et al. Among authors: gill bj. Future Oncol. 2024 Mar;20(10):579-591. doi: 10.2217/fon-2023-0702. Epub 2023 Dec 7. Future Oncol. 2024. PMID: 38060340 Free article.
MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas.
Kinslow CJ, Rae AI, Taparra K, Kumar P, Siegelin MD, Grinband J, Gill BJA, McKhann GM, Sisti MB, Bruce JN, Canoll PD, Iwamoto FM, Horowitz DP, Kachnic LA, Neugut AI, Yu JB, Cheng SK, Wang TJC. Kinslow CJ, et al. Among authors: gill bja. Clin Cancer Res. 2023 Nov 1;29(21):4399-4407. doi: 10.1158/1078-0432.CCR-23-1295. Clin Cancer Res. 2023. PMID: 37611077 Free PMC article.
Re-convolving the compositional landscape of primary and recurrent glioblastoma reveals prognostic and targetable tissue states.
Al-Dalahmah O, Argenziano MG, Kannan A, Mahajan A, Furnari J, Paryani F, Boyett D, Save A, Humala N, Khan F, Li J, Lu H, Sun Y, Tuddenham JF, Goldberg AR, Dovas A, Banu MA, Sudhakar T, Bush E, Lassman AB, McKhann GM, Gill BJA, Youngerman B, Sisti MB, Bruce JN, Sims PA, Menon V, Canoll P. Al-Dalahmah O, et al. Among authors: gill bja. Nat Commun. 2023 May 4;14(1):2586. doi: 10.1038/s41467-023-38186-1. Nat Commun. 2023. PMID: 37142563 Free PMC article.
43 results